Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

MR CLEAN, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study protocol for a randomized controlled trial.

Fransen PS, Beumer D, Berkhemer OA, van den Berg LA, Lingsma H, van der Lugt A, van Zwam WH, van Oostenbrugge RJ, Roos YB, Majoie CB, Dippel DW; MR CLEAN Investigators.

Trials. 2014 Sep 1;15:343. doi: 10.1186/1745-6215-15-343.

2.

Comparison of time to treatment between intravenous and endovascular thrombolytic treatments for acute ischemic stroke.

Asaithambi G, Hassan AE, Chaudhry SA, Rodriguez GJ, Suri MF, Taylor RA, Ezzeddine MA, Qureshi AI.

J Vasc Interv Neurol. 2011 Jul;4(2):15-20.

3.

Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence.

Vivien D, Gauberti M, Montagne A, Defer G, Touzé E.

J Cereb Blood Flow Metab. 2011 Nov;31(11):2119-34. doi: 10.1038/jcbfm.2011.127. Epub 2011 Aug 31. Review.

4.

Safety and efficacy of alteplase in the treatment of acute ischemic stroke.

Micieli G, Marcheselli S, Tosi PA.

Vasc Health Risk Manag. 2009;5(1):397-409. Review.

5.

Methodology of the Interventional Management of Stroke III Trial.

Khatri P, Hill MD, Palesch YY, Spilker J, Jauch EC, Carrozzella JA, Demchuk AM, Martin R, Mauldin P, Dillon C, Ryckborst KJ, Janis S, Tomsick TA, Broderick JP; Interventional Management of Stroke III Investigators.

Int J Stroke. 2008 May;3(2):130-7. doi: 10.1111/j.1747-4949.2008.00151.x.

6.

Interventional neuroradiology.

Renowden S.

J Neurol Neurosurg Psychiatry. 2005 Sep;76 Suppl 3:iii48-iii63. Review. No abstract available.

Supplemental Content

Support Center